Inotropic/vasopressor support in critically ill patients...when to cho

Inotropic/vasopressor support in critically ill patients...when to choose,how to choose,and how much dose

Reading File

Finding Sources

Searching PubMed

vasopressors AND shock

Searching the Web

Surviving Sepsis Campaign 2021 vasopressor norepinephrine vasopressin dosing guideline

Reading File

Finding Sources

Reading File

Finding Sources

Core principle

Choose vasoactive support by identifying the dominant hemodynamic failure:

Vasoplegia / low SVR: hypotension with warm peripheries, often high or normal cardiac output. Use a vasopressor.
Pump failure / low cardiac output: cool peripheries, pulmonary edema or raised filling pressures, low stroke volume. Use an inotrope, often with a vasopressor if hypotensive.
Hypovolemia or hemorrhage: replace volume and control bleeding first. Vasopressors can be a temporary bridge, not definitive therapy.
Obstruction: relieve the obstruction, such as tamponade drainage, reperfusion for massive PE, tension pneumothorax decompression. Pressors are bridging treatment.

After initial resuscitation, start vasoactive support when hypotension plus signs of inadequate organ perfusion persist: altered mentation, oliguria, rising lactate, cold/mottled skin, low ScvO2, or worsening metabolic acidosis. A usual initial target is MAP at least 65 mmHg, individualized upward in some patients with chronic hypertension or cerebral/renal perfusion concerns. Blood pressure alone is not adequate: assess urine output, mentation, capillary refill, lactate trend, bedside echocardiography, and cardiac output where available.
Harrison’s Principles of Internal Medicine, 22e, p. 2358.

First decide: pressor, inotrope, or both?

Dominant problem	Hemodynamic pattern	Preferred approach
Distributive shock: septic, vasoplegic postoperative, neurogenic	Low SVR, often warm; CO may be normal/high	Norepinephrine first-line
Septic shock with persistent vasoplegia	Rising norepinephrine requirement	Add fixed-dose vasopressin; then consider epinephrine
Septic shock with myocardial dysfunction/low CO despite adequate MAP and volume	Low contractility/CO, persistent hypoperfusion	Add dobutamine to norepinephrine, or use epinephrine
Cardiogenic shock with hypotension	Low CO, high filling pressures, cold/wet	Norepinephrine to restore perfusion pressure, plus dobutamine if low output persists; urgent echo and cause-specific treatment/revascularization
Cardiogenic shock with adequate BP but low output	Low CO without major hypotension	Dobutamine or sometimes milrinone, selected case-by-case
Anaphylactic shock	Vasodilation, capillary leak, bronchospasm	IM epinephrine immediately. IV epinephrine infusion only for refractory shock in a closely monitored setting
Neurogenic shock	Vasodilation with relative bradycardia	Norepinephrine usually preferred; treat clinically significant bradycardia separately
Hemorrhagic shock	Low preload from blood loss	Blood products, hemorrhage control, damage-control resuscitation. Norepinephrine only as a short bridge for profound hypotension
Obstructive shock	Tamponade, massive PE, tension pneumothorax	Fix obstruction. Norepinephrine is commonly used while definitive therapy occurs

Vasopressors are not first-line treatment for pure hypovolemia because inadequate preload plus vasoconstriction can worsen coronary and tissue perfusion.
Bailey and Love’s Short Practice of Surgery, 28e, p. 37.

Practical adult ICU starting doses

These are typical continuous-infusion ranges for adults, not substitutes for local drug concentrations, pump libraries, and senior ICU/ED supervision. Titrate every few minutes during unstable shock, then reassess frequently.

Drug	Main action	When to choose	Typical start and titration	Common practical range	Major cautions
Norepinephrine	Strong alpha-1 vasoconstriction, modest beta-1 inotropy	First-line in septic/distributive shock; preferred pressor in hypotensive cardiogenic shock	Start 0.02-0.05 mcg/kg/min, titrate to MAP/perfusion	Often 0.05-0.5 mcg/kg/min; higher doses may be required temporarily	Arrhythmia, ischemia, peripheral/digital ischemia, extravasation
Vasopressin	V1 vasoconstriction, non-catecholamine	Add-on in septic/vasoplegic shock when norepinephrine dose is escalating	Usually fixed 0.03 units/min	0.03-0.04 units/min, generally not titrated upward routinely	Digital/mesenteric ischemia at higher doses; do not use as sole initial agent in septic shock
Epinephrine	Beta-1 inotropy/chronotropy plus alpha vasoconstriction at higher doses	Refractory septic shock after norepinephrine plus vasopressin; anaphylaxis; shock needing both inotropy and vasoconstriction	Start 0.02-0.05 mcg/kg/min	Roughly 0.02-0.5 mcg/kg/min, individualized	Tachyarrhythmias, myocardial ischemia, hyperlactatemia/lactic acidosis, hyperglycemia
Dobutamine	Predominantly beta-1 inotropy; some beta-2 vasodilation	Low-output state with impaired contractility, especially cardiogenic shock or septic myocardial dysfunction after pressure is supported	Start 2-5 mcg/kg/min	2-15 mcg/kg/min	Can lower BP, tachyarrhythmia, ischemia. Combine with norepinephrine if hypotensive
Phenylephrine	Pure alpha-1 vasoconstrictor	Narrow role: severe tachyarrhythmia limiting beta-agonists, anesthesia-associated vasodilation	Start 0.1-0.5 mcg/kg/min or institution-specific mcg/min infusion	Variable by protocol	May reduce stroke volume and tissue perfusion; not routine septic-shock first-line therapy
Milrinone	PDE-3 inodilator	Low-output cardiogenic shock, especially patient on chronic beta-blocker or with RV failure/pulmonary hypertension, only if BP can tolerate it	Often 0.125-0.25 mcg/kg/min, avoid loading dose in shock	0.125-0.75 mcg/kg/min	Hypotension, arrhythmia; reduce/avoid in renal failure due to accumulation
Dopamine	Dose-dependent dopaminergic, beta, alpha effects	Rarely selected, sometimes if shock plus marked bradycardia and low arrhythmia risk	5-20 mcg/kg/min	5-20 mcg/kg/min	More tachyarrhythmias; avoid as routine first-line shock drug. “Renal-dose” dopamine has no role

The cited emergency medicine table lists dobutamine 2-15 mcg/kg/min, epinephrine 5-20 mcg/min, norepinephrine 3-30 mcg/min, phenylephrine 2-300 mcg/min, and vasopressin 0.01-0.04 units/min. Weight-based dosing is often safer for catecholamine infusions if supported by the local pump protocol.
Rosen’s Emergency Medicine, 10e, p. 1907.

A usable escalation algorithm for septic/vasodilatory shock

Confirm that shock is present and treat the cause at once
Obtain cultures where appropriate, give timely antimicrobials in suspected sepsis, achieve source control, correct hypoxemia, and assess fluid responsiveness rather than giving unlimited fluids.
Start norepinephrine early if MAP is low with hypoperfusion.
Peripheral administration through a well-sited proximal IV can be used briefly while central access is arranged, with close checks for extravasation. Do not delay life-saving pressors solely to obtain a central line.
Titrate to MAP and perfusion, not to an arbitrary high dose.
Start with MAP 65 mmHg for most adults, then individualize.
If norepinephrine is approaching about 0.25-0.5 mcg/kg/min and MAP remains inadequate, add vasopressin 0.03 units/min rather than simply escalating norepinephrine indefinitely.
If still hypotensive, add epinephrine.
If MAP is adequate but hypoperfusion persists with low cardiac output or echo evidence of myocardial dysfunction, add dobutamine, usually while maintaining norepinephrine.

This sequence aligns with the Surviving Sepsis Campaign recommendations: norepinephrine first, vasopressin as an adjunct when norepinephrine is escalating, and epinephrine if hypotension continues. Barash, Cullen, and Stoelting’s Clinical Anesthesia, 9e, p. 4831.

Cardiogenic shock: avoid the common mistake

In cardiogenic shock, a drug that raises contractility but lowers SVR can worsen hypotension. A practical approach:

Low MAP: start norepinephrine first to preserve coronary and cerebral perfusion.
Low CO persists after MAP is acceptable: add dobutamine 2-5 mcg/kg/min, titrating with echo, cardiac output, perfusion, and arrhythmia surveillance.
Consider milrinone in selected cases, particularly chronic beta-blockade or RV failure/pulmonary hypertension, but it is longer-acting and harder to reverse if hypotension develops.
Seek and treat the cause urgently: acute coronary syndrome, mechanical complication, myocarditis, severe valve lesion, arrhythmia, or RV infarct/PE. Consider mechanical circulatory support early in refractory cases.

For mixed septic-cardiogenic shock, norepinephrine plus dobutamine permits independent titration of vascular tone and contractility.
Harrison’s Principles of Internal Medicine, 22e, p. 2358.

Safety and monitoring checklist

Prefer an arterial line for ongoing or escalating pressor support.
Continuous ECG and SpO2, frequent temperature and limb-perfusion checks.
Hourly urine output, serial lactate, mental status, capillary refill, skin mottling.
Use bedside echo to reassess LV/RV function, preload, and alternative diagnoses.
Look repeatedly for arrhythmia, myocardial ischemia, acidosis, peripheral ischemia, and extravasation.
Correct hypoxia, acidosis, hypocalcemia, and ongoing hypovolemia, since all reduce vasoactive-drug effectiveness.
Once the cause is controlled and perfusion improves, wean the agent with the least ongoing physiologic need, usually catecholamines first if vasopressin is being used as a fixed adjunct.
Escalating requirements, especially norepinephrine above roughly 0.5-1 mcg/kg/min, should trigger a diagnostic reset: uncontrolled source, occult hemorrhage, tamponade, PE, adrenal insufficiency, abdominal compartment syndrome, incorrect shock phenotype, or inadequate source control.

Recent syntheses remain consistent with norepinephrine as the anchor for vasodilatory shock, but they do not establish a single universally superior adjunct for all patients. A 2025 systematic review and meta-analysis and a 2024 meta-analysis of non-adrenergic pressors support individualized adjunct selection rather than reflexive multi-pressor escalation.

This is a shared conversation. Sign in to Orris to start your own chat.